1.82850 EUR
0.0345
1.85%
Last update Dec 16, 9:55 PM CET
Market closed
Day range
1.82550
1.87450
Previous close
1.86300
Open
1.84950
Access this stock data via API
Subscribe
ImmunityBio, Inc.
1.83
0.03
1.85%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 12.6M 622K 240K 934K
Cost of revenue 0
Gross profit 12.6M
Operating expense
Research & development 162.1M 232.4M 248.1M 196.0M
Selling general and admin 143.8M 129.6M 102.7M 135.3M
Other operating expenses
Operating income -293.3M -361.4M -350.6M -330.3M
Non operating interest income
Income 2.0M 863K 2.7M 836K
Expense 112.2M 129.2M 63.5M 14.8M
Other income expense 70.3M -94.2M -5.9M -5.5M
Pretax income -352.5M -583.9M -417.3M -349.8M
Tax provision 0 -40K 34K 9K
Net income -352.5M -583.9M -417.3M -349.8M
Basic EPS -0.6 -1.2 -1.0 -0.9
Diluted EPS -0.6 -1.2 -1.0 -0.9
Basic average shares 594.3M 533.4M 419.3M 408.1M
Diluted average shares 594.3M 533.4M 419.3M 408.1M
EBITDA -258.6M -388.0M -342.5M -315.8M
Net income from continuing op. -352.5M -583.9M -417.3M -349.8M
Minority interests 81K 656K 753K 3.1M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 4 hours 24 minutes

03:35
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).